SUNESIS PHARMACEUTICALS INC's ticker is and the CUSIP is 867328901. A total of 3 filers reported holding SUNESIS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $12,000 | +71.4% | 22,000 | +73.2% | 0.00% | – |
Q1 2016 | $7,000 | -46.2% | 12,700 | -12.4% | 0.00% | – |
Q4 2015 | $13,000 | +44.4% | 14,500 | +34.3% | 0.00% | – |
Q3 2015 | $9,000 | -60.9% | 10,800 | +42.1% | 0.00% | – |
Q2 2015 | $23,000 | -70.5% | 7,600 | -76.1% | 0.00% | – |
Q1 2015 | $78,000 | +34.5% | 31,800 | +39.5% | 0.00% | – |
Q4 2014 | $58,000 | -95.5% | 22,800 | -87.5% | 0.00% | -100.0% |
Q3 2014 | $1,302,000 | +693.9% | 182,300 | +626.3% | 0.00% | – |
Q2 2014 | $164,000 | +54.7% | 25,100 | +55.9% | 0.00% | – |
Q1 2014 | $106,000 | – | 16,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 4,079 | $2,912,000 | 0.11% |
GROUP ONE TRADING, L.P. | 714,500 | $5,102,000 | 0.08% |
Citadel Advisors | 182,300 | $1,302,000 | 0.00% |